Naples Community Hospital

Naples, Florida 34109

4 studies enrolling now · 18 studies all time

What they study most

Atrial Fibrillation, Bleeding, Bradycardia, Brain Infarction, Breast Cancer, Cerebral Ischemia, Delirium, Euvolemic Hyponatremia, Heart Failure, Hypervolemic Hyponatremia, Ischemic Stroke, Mitral Regurgitation

Studies at this site

• GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study — Recruiting now
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias — Recruiting now
• The ENCIRCLE Trial — Recruiting now
• The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry) — Recruiting now
• The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. — Recruiting now
• Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day — Recruiting now
• Ceribell Delirium Data Collection Study — Recruiting now
• SIMPLAAFY Clinical Trial — Running, not enrolling
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation — Completed
• CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer — Status unconfirmed
• COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device — Completed
• Cryoablation of Small Breast Tumors in Early Stage Breast Cancer — Status unconfirmed
• Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System — Completed
• Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia — Completed
• Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) — Completed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early